المؤلفون: Pierpaolo Pellicori, Blerim Mujaj, Stephane Heymans, Fozia Z Ahmed, N. Girerd, Ping Wang, Arantxa González, Hans-Peter Brunner-La-Rocca, Javier Díez, Franco Cosmi, Frank T. Edelmann, Mark R. Hazebroek, João Pedro Ferreira, Joe Cuthbert, Andrew L. Clark, Johannes Petutschnigg, Mamas A. Mamas, Roberto Latini, Job A J Verdonschot, John G.F. Cleland, Beatrice Mariottoni, Patrick Rossignol, Javed Khan, Jan A. Staessen, Burkert Pieske, Faiez Zannad, Anne Pizard, Stéphanie Grojean, Timothy Collier, Philippe Rouet

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], London School of Hygiene and Tropical Medicine (LSHTM), University of Manchester [Manchester], University of Hull [United Kingdom], Cortona Hospital, Universidad de Navarra [Pamplona] (UNAV), German Heart Institute Berlin, University of Glasgow, Mario Negri Institute, Center for Human Genetics, University of Leuven School of Medicine, SCHOOL of MEDICINE [Louvain], Université Catholique de Louvain = Catholic University of Louvain (UCL)-Université Catholique de Louvain = Catholic University of Louvain (UCL), Centre d'anthropologie et de génomique de Toulouse (CAGT), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Author Disclosures HOMAGE was funded by a grant from the European Union 7th Framework Programme for Research and Technological Development (HEALTH-F7-305507 HOMAGE (EU FP7 305507 http://www.homage-hf.euTest). Drs. Ferreira, Rossignol, Girerd, and Zannad are supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d’Avenir' program (reference: ANR-15-RHUS-0004), the French PIA project 'Lorraine Université d’Excellence' (reference: ANR-15-IDEX-04-LUE), Contrat de Plan Etat Lorraine IT2MP, and FEDER Lorraine. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre National de la Recherche Scientifique (CNRS), DE CARVALHO, Philippe, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, Heart OMics in AGEing - HOMAGE - - EC:FP7:HEALTH2013-02-01 - 2019-01-31 - 305507 - VALID, RS: Carim - H02 Cardiomyopathy, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), MUMC+: MA Med Staf Artsass Cardiologie (9)

المصدر: JACC: Heart Failure
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD

مصطلحات موضوعية: Male, Proteomics, [SDV]Life Sciences [q-bio], Adipokine, Inflammation, 030204 cardiovascular system & hematology, Pharmacology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Mineralocorticoid receptor, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Fibrosis, Renin–angiotensin system, Natriuretic Peptide, Brain, medicine, Humans, 030212 general & internal medicine, Aged, Mineralocorticoid Receptor Antagonists, Heart Failure, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, business.industry, fibrosis, spironolactone, HEART-FAILURE INSIGHTS, medicine.disease, Brain natriuretic peptide, 3. Good health, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, CARDIAC MATRIX BIOMARKERS, [SDV] Life Sciences [q-bio], renin-angiotensin-aldosterone system, chemistry, MYOCARDIAL-INFARCTION, inflammation, Heart failure, Spironolactone, SURVIVAL, EPLERENONE, Female, medicine.symptom, Cardiology and Cardiovascular Medicine, business, heart failure prevention, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff2f9ef636912f7d1efd60c7c971fbe4Test
https://cris.maastrichtuniversity.nl/en/publications/f2280d92-dac9-4b92-a4fa-39b9afb82d38Test

المؤلفون: Finnian R. Mc Causland, João Pedro Ferreira, Brian Claggett, John J.V. McMurray, Ebrahim Barkoudah, Faiez Zannad, Scott D. Solomon, Akshay S. Desai, Karola S. Jering, Marc A. Pfeffer

المصدر: JACC: Heart Failure. 9:13-24

مصطلحات موضوعية: Male, medicine.medical_specialty, Tetrazoles, Renal function, Angiotensin-Converting Enzyme Inhibitors, 030204 cardiovascular system & hematology, Kidney, Ventricular Function, Left, Sacubitril, Angiotensin Receptor Antagonists, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Humans, Prospective Studies, 030212 general & internal medicine, Mineralocorticoid Receptor Antagonists, Heart Failure, Creatinine, Ejection fraction, business.industry, Aminobutyrates, Stroke Volume, medicine.disease, Drug Combinations, Treatment Outcome, chemistry, Valsartan, Heart failure, Cardiology, Cardiology and Cardiovascular Medicine, Heart failure with preserved ejection fraction, business, Sacubitril, Valsartan, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73244f805ec77c03d307100234f1c09eTest
https://doi.org/10.1016/j.jchf.2020.08.014Test

المؤلفون: Milton Packer, Waheed Jamal, Stefan D. Anker, Stuart J. Pocock, João Pedro Ferreira, Javed Butler, Anne Pernille Ofstad, Gerasimos Filippatos, Martina Brueckmann, Egon Pfarr, Faiez Zannad

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), London School of Hygiene and Tropical Medicine (LSHTM), Berlin Institute of Health (BIH), Department of Medicine, University of Washington [Seattle], Imperial College London

المصدر: Lancet
Lancet, Elsevier, 2020, 396, pp.819-829. ⟨10.1016/S0140-6736(20)31824-9⟩

مصطلحات موضوعية: Male, medicine.medical_specialty, [SDV]Life Sciences [q-bio], Type 2 diabetes, 030204 cardiovascular system & hematology, Body Mass Index, Angiotensin Receptor Antagonists, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Glucosides, Cause of Death, Internal medicine, Diabetes mellitus, Empagliflozin, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, Benzhydryl Compounds, Dapagliflozin, Sodium-Glucose Transporter 2 Inhibitors, Aged, Heart Failure, Clinical Trials as Topic, Ejection fraction, business.industry, Hazard ratio, Stroke Volume, General Medicine, Middle Aged, medicine.disease, 3. Good health, Death, Hospitalization, Patient Outcome Assessment, Diabetes Mellitus, Type 2, chemistry, Case-Control Studies, Heart failure, Cardiology, Drug Therapy, Combination, Female, Neprilysin, business, Glomerular Filtration Rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b80a4812ab235e41f47b4573d502cdTest
https://doi.org/10.1016/s0140-6736Test(20)31824-9

المؤلفون: Andrew L. Clark, Javier Díez, Pierpaolo Pellicori, Investigators, Nicolas Girerd, Job A J Verdonschot, João Pedro Ferreira, Susana Ravassa, Frank Edelmann, Stephane Heymans, Beatrice Mariottoni, María U. Moreno, Homage Trial Committees, Franco Cosmi, Jan A. Staessen, Burkert Pieske, John G.F. Cleland, Faiez Zannad, Johannes Petutschnigg, Mark R. Hazebroek, Joe Cuthbert, Arantxa González, Begoña López, Erwan Bozec

المساهمون: Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain, CIBERCV, Carlos III Institute of Health, Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow Royal Infirmary, Department of Cardiology, Cortona Hospital, Department of Cardiology, Maastricht University Medical Center, Cardiology Department, Castle Hill Hospital, University of Hull, Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, and German Centre for Cardiovascular research (DZHK), Partner Site Berlin, Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine, Mechelen (APPREMED), Biomedical Sciences Group, Faculty of Medicine, University of Leuven, Berlin Institute of Health (BIH), Departments of Nephrology and Cardiology, Clínica Universidad de Navarra, This work was supported by the European Commission HOMAGE project (grant 305507), JD and AG are supported by the Ministry of Science and Innovation, Spain (Instituto de Salud Carlos III: CB16/11/00483 and PI18/01469 co-financed by FEDER funds). MH is supported by a Kootstra Talented Post-doc Fellowship (Netherlands). JGFC and PP are supported by the British Heart Foundation Centre of Research Excellence (grant number RE/18/6/34217). PPREMED (URL: http://www.appremed.orfTest) received a non-binding grant from Omron Healthcare Co., Ltd., Kyoto, Japan., European Project: 305507, BOZEC, Erwan, HOMAGE (Heart Omics in Ageing consortium) - 305507 - INCOMING, MUMC+: MA Med Staf Artsass Cardiologie (9), RS: Carim - H02 Cardiomyopathy, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9)

المصدر: European Journal of Heart Failure
European Journal of Heart Failure, European Society of Cardiology (Wiley), 2021, ⟨10.1002/ejhf.2394⟩
Dadun. Depósito Académico Digital de la Universidad de Navarra
Consejo Superior de Investigaciones Científicas (CSIC)
European Journal of Heart Failure, Oxford University Press (OUP), 2021, ⟨10.1002/ejhf.2394⟩
European journal of heart failure, 24(2), 321-331. Wiley

مصطلحات موضوعية: Cardiac function curve, medicine.medical_specialty, Cardiac & Cardiovascular Systems, Heart failure, 030204 cardiovascular system & hematology, Spironolactone, EXERCISE CAPACITY, Atrial remodelling, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, N-terminal telopeptide, Left atrial, Collagen cross-linking, Internal medicine, MAGNETIC-RESONANCE, medicine, FIBROSIS, 030212 general & internal medicine, Science & Technology, Ejection fraction, business.industry, medicine.disease, DYSFUNCTION, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, PRESERVED EJECTION FRACTION, chemistry, VOLUME, Cardiovascular System & Cardiology, SURVIVAL, Cardiology, Biomarker (medicine), FIBRILLATION, Cardiology and Cardiovascular Medicine, business, Life Sciences & Biomedicine, Blood sampling

وصف الملف: application/pdf; Print-Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23cf6004dd43e1e3a891d35bf846cb9cTest
https://hdl.handle.net/10171/63765Test

المؤلفون: Pierpaolo Pellicori, Patrick Rossignol, Hans-Peter Brunner-La Rocca, Faiez Zannad, John G.F. Cleland, Nicolas Girerd, João Pedro Ferreira

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], Maastricht University [Maastricht], University of Glasgow, Contrat de Plan État Lorraine IT2MP and FEDER Lorraine, ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013), DE CARVALHO, Philippe, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, Heart OMics in AGEing - HOMAGE - - EC:FP7:HEALTH2013-02-01 - 2019-01-31 - 305507 - VALID, RS: Carim - H02 Cardiomyopathy, MUMC+: MA Med Staf Spec Cardiologie (9), Cardiologie

المصدر: Archives of Cardiovascular Diseases
Archives of cardiovascular diseases
Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2021, 114 (12), pp.814-817. ⟨10.1016/j.acvd.2021.10.003⟩
Archives of Cardiovascular Diseases, 114(12), 814-817. Elsevier Masson

مصطلحات موضوعية: MRA, mineralocorticoid receptor antagonist, 2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), HOMAGE, Heart OMics in AGEing, ACE, angiotensin-converting enzyme, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ACE2, Angiotensin-Converting Enzyme Inhibitors, 030204 cardiovascular system & hematology, Pharmacology, Peptidyl-Dipeptidase A, Spironolactone, law.invention, Renin-Angiotensin System, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Research Letter, Medicine, Humans, 030212 general & internal medicine, ComputingMilieux_MISCELLANEOUS, RISK, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, ARB, angiotensin-receptor blocker, RECEPTOR, business.industry, SARS-CoV-2, COVID-19, General Medicine, chemistry, Angiotensin-converting enzyme 2, Plasma concentration, Angiotensin-Converting Enzyme 2, Cardiology and Cardiovascular Medicine, business, NPX, normalized protein expression, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::922126c27bd5bd12a6081211403cc3feTest
http://europepmc.org/articles/PMC8576594Test

المؤلفون: João Pedro Ferreira, Susan Stienen, Kenneth Dickstein, Faiez Zannad, Jozine M. ter Maaten, Chim C. Lang, Gregoire Preud'homme, Leong L. Ng, Nilesh J. Samani, Zohra Lamiral, Patrick Rossignol, Masatake Kobayashi, Adriaan A. Voors, M. Metra, Stefan D. Anker, Dirk J. van Veldhuisen, Kevin Duarte, Nicolas Girerd

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), University Medical Center Groningen [Groningen] (UMCG), University of Bergen (UiB), Department of Cardiology, Stavanger University Hospital, Department of Cardiovascular Sciences [Leicester], University of Leicester, Leicester NIHR Biomedical Research Unit in Cardiovascular Disease, University of Dundee, Ninewells Hospital and Medical School [Dundee], Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research (DZHK) partner site Berlin, University of Brescia, Civic Hospital of Brescia, This project was funded by a grant from the European Commission (FP7-242209-BIOSTAT-CHF, EudraCT 2010–020808–29). JPF, NG, PR and FZ are supported by a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d’Avenir' program FIGHT-HF (reference: ANR-15-RHU-0004) and by the French PIA project 'Lorraine Université d’Excellence', reference ANR-15-IDEX-04-LUE. And by Contrat de Plan Etat-Région and FEDER Lorraine., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 242209,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,BIOSTAT-CHF(2010), European Project, Cardiovascular Centre (CVC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), BOZEC, Erwan, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure - BIOSTAT-CHF - - EC:FP7:HEALTH2010-04-01 - 2015-03-31 - 242209 - VALID, EudraCT 2010–020808–29 - INCOMING

المصدر: ESC Heart Failure
ESC Heart Failure, Wiley, 2020, 7 (3), pp.953-963. ⟨10.1002/ehf2.12634⟩
ESC Heart Failure, Vol 7, Iss 3, Pp 953-963 (2020)
ESC Heart Failure, 7(3), 953-963. WILEY PERIODICALS, INC
ESC Heart Failure, 2020, 7 (3), pp.953-963. ⟨10.1002/ehf2.12634⟩

مصطلحات موضوعية: medicine.medical_specialty, lcsh:Diseases of the circulatory (Cardiovascular) system, BASE-LINE, Renal function, Heart failure, 030204 cardiovascular system & hematology, THERAPY, DISEASE, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Mineralocorticoid receptor, LEFT-VENTRICULAR DYSFUNCTION, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Prediction model, Internal medicine, Original Research Articles, Renin–angiotensin system, Renin, medicine, Humans, 030212 general & internal medicine, Original Research Article, Aldosterone, Mineralocorticoid Receptor Antagonists, PLASMA, business.industry, MORTALITY, medicine.disease, Prognosis, Angiotensin II, SPIRONOLACTONE, Pathophysiology, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, ANGIOTENSIN-II, ADIPOSE-TISSUE, chemistry, lcsh:RC666-701, Spironolactone, Cardiology, Cardiology and Cardiovascular Medicine, business, SYSTEM

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4867b324b8af9ffe434292e456c51d76Test
https://hdl.handle.net/11370/4a2fcf12-1631-4aa8-b37e-f73cf7a20c48Test

المؤلفون: Jyothis T. George, Faiez Zannad, Christoph Wanner, João Pedro Ferreira, Anne Pernille Ofstad, Isabella Zwiener, Sabine Lauer, Bernard Zinman, Audrey Koitka-Weber, David Fitchett, B. Kraus

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), University of Würzburg = Universität Würzburg, University Hospital of Würzburg, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Lunenfeld-Tanenbaum Research Institute [Toronto, Canada], St. Michael's Hospital, University of Toronto, University of Melbourne, Boehringer Ingelheim Norway KS, This study was funded by the Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance.

المصدر: Journal of the American Heart Association
Journal of the American Heart Association, Wiley-Blackwell, 2021, 10 (7), pp.e020053. ⟨10.1161/JAHA.120.020053⟩
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

مصطلحات موضوعية: medicine.medical_specialty, Cardiorenal Syndrome, win ratio, empagliflozin, 030204 cardiovascular system & hematology, Kidney, Brief Communication, Outcome (game theory), 03 medical and health sciences, chemistry.chemical_compound, hazard ratio, 0302 clinical medicine, Glucosides, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Risk Factors, Internal medicine, Post-hoc analysis, cardio‐renal, Empagliflozin, medicine, Humans, Hypoglycemic Agents, 030212 general & internal medicine, Benzhydryl Compounds, Sodium-Glucose Transporter 2 Inhibitors, business.industry, Hazard ratio, cardio/kidney composite end points, 3. Good health, medicine.anatomical_structure, chemistry, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Cardiology, Cardiology and Cardiovascular Medicine, business, EMPA, Glomerular Filtration Rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a6cefe8462ff5f079ebe57b8c9cab5bTest
https://hal.univ-lorraine.fr/hal-03237043/file/JAHA.120.020053.pdfTest

المؤلفون: Gerald Roul, Nicolas Girerd, João Pedro Ferreira, David Kenizou, Patrick Rossignol, Bruno Levy, Pascal Bilbault, Tahar Chouihed, François Braun, Pierre Nazeyrollas, Marie F Seronde, Noura Zannad

المصدر: European Journal of Emergency Medicine. 25:229-236

مصطلحات موضوعية: Male, medicine.medical_specialty, Critical Care, Critical Illness, Renal function, Comorbidity, 030204 cardiovascular system & hematology, Risk Assessment, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, medicine, Humans, Hospital Mortality, Renal Insufficiency, 030212 general & internal medicine, Disease management (health), Intensive care medicine, Survival rate, Heart Failure, Creatinine, business.industry, Disease Management, Emergency department, medicine.disease, Combined Modality Therapy, Survival Rate, Treatment Outcome, chemistry, Concomitant, Heart failure, Acute Disease, Disease Progression, Emergency Medicine, Female, France, Emergency Service, Hospital, business, Glomerular Filtration Rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22845dd2b8620e83af2ab0c74efbbb1bTest
https://doi.org/10.1097/mej.0000000000000505Test

المؤلفون: Lutgarde Thijs, Beatrice Mariottoni, Johannes Petutschnigg, Andrew L. Clark, Mamas A. Mamas, Patrick Rossignol, Frank Edelmann, Pierpaolo Pellicori, Timothy Collier, Franco Cosmi, Fozia Z Ahmed, Arantxa González, João Pedro Ferreira, Blerim Mujaj, Mark R. Hazebroek, Joe Cuthbert, Philippe Rouet, Stephane Heymans, Hans-Peter Brunner-La Rocca, Nicolas Girerd, Job A J Verdonschot, Jan A. Staessen, John G.F. Cleland, Faiez Zannad

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), London School of Hygiene and Tropical Medicine (LSHTM), University of Hull [United Kingdom], Castle Hill Hospital, University of Manchester [Manchester], Manchester Academic Health Science Centre (MAHSC), Keele University [Keele], Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], Center for Applied Medical Research [Plamplona] (CIMA), Universidad de Navarra [Pamplona] (UNAV), Clínica Universidad de Navarra [Pamplona], CIBERCV, Carlos III Institute of Health, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Charité Campus Virchow-Klinikum (CVK), Universitäts Klinikum Freiburg = University Medical Center Freiburg (Uniklinik), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), University of Glasgow, Cortona Hospital, Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), HOMAGE was funded by a grant from the European Union 7th Framework Programme for Research and Technological Development (HEALTH-F7-305507 HOMAGE (EU FP7 305507 http://www.homage-hf.euTest). JPF, PR, NG, FZ are supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d’Avenir' program (reference: ANR-15-RHUS-0004), by the French PIA project 'Lorraine Université d’Excellence' (reference: ANR-15-IDEX-04-LUE), Contrat de Plan Etat Lorraine IT2MP and FEDER Lorraine., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 305507,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HOMAGE(2013), European Project, Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Freiburg University Medical Center, Hôpital de Rangueil, CHU Toulouse [Toulouse], Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy, MUMC+: MA Med Staf Artsass Cardiologie (9), BOZEC, Erwan, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, Heart OMics in AGEing - HOMAGE - - EC:FP7:HEALTH2013-02-01 - 2019-01-31 - 305507 - VALID, Entreprises lorraines, parties prenantes et Développement Durable (FEDER) (Région Lorraine) - INCOMING

المصدر: European Heart Journal-Cardiovascular Pharmacotherapy
European Heart Journal-Cardiovascular Pharmacotherapy, 2021, ⟨10.1093/ehjcvp/pvab031⟩
European Heart Journal-Cardiovascular Pharmacotherapy, Oxford Academy, 2021, ⟨10.1093/ehjcvp/pvab031⟩
European Heart Journal-Cardiovascular Pharmacotherapy, 8(2), 149-156. Oxford University Press

مصطلحات موضوعية: cardiovascular risk, Male, medicine.medical_specialty, ALDOSTERONISM, hypertension, IMPACT, Developing heart, Blood Pressure, 030204 cardiovascular system & hematology, Spironolactone, Sitting, Coronary artery disease, RESISTANT HYPERTENSION, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Internal medicine, Diabetes mellitus, Renin–angiotensin system, medicine, MANAGEMENT, FIBROSIS, Humans, Pharmacology (medical), 030212 general & internal medicine, Prospective Studies, Aged, Mineralocorticoid Receptor Antagonists, Heart Failure, business.industry, R735, medicine.disease, Omics, RC666, R1, PREVENTION, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Blood pressure, spironolactone, chemistry, renin, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, TASK-FORCE

وصف الملف: application/pdf; Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51291ffb39695fa7fd47e8e135cb3fa6Test
https://pubmed.ncbi.nlm.nih.gov/33822033Test

المؤلفون: Giuseppe Mancia, Thomas Weber, Reinhold Kreutz, Otto A. Smiseth, Kristian Wachtell, Faiez Zannad, Sverre E. Kjeldsen, Enrico Agabiti Rosei, Athanasios J. Manolis, Konstantinos Tsioufis, João Pedro Ferreira, Miguel Camafort, Thomas G. von Lueder, Georg Ehret, Alexandros Kasiakogias, Andrzej Januszewicz, Thomas Kahan, Jana Brguljan, Luca Faconti

مصطلحات موضوعية: medicine.medical_specialty, Finerenone, Physiology, Angiotensin-Converting Enzyme Inhibitors, 030204 cardiovascular system & hematology, law.invention, Angiotensin Receptor Antagonists, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Diabetes mellitus, Internal Medicine, medicine, Humans, 030212 general & internal medicine, Risk factor, Intensive care medicine, Heart Failure, business.industry, Stroke Volume, medicine.disease, Blood pressure, chemistry, Heart failure, Hypertension, Spironolactone, Cardiology and Cardiovascular Medicine, business, Heart failure with preserved ejection fraction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65a1c2bd18e7752775c603525b4c2795Test
http://hdl.handle.net/10852/92304Test